Bao; Jianming

Patent Applications and Registrations

Patent applications and USPTO patent grants for Bao; Jianming.The latest application filed is for "preparation of benzimidazolone derivatives as novel diacylglyceride o-acyltransferase 2 inhibitors".

Company Profile

14.29.33

Bao; Jianming - San Mateo CA
Bao; Jianming - Princeton NJ
Bao; Jianming - South San Francisco CA
Bao; Jianming - Shanghai CN
Bao; Jianming - Scotch Plains NJ
Bao; Jianming - Westfield NJ

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
3-(1H-pyrazol-4-yl)pyridine allosteric modulators of the M4 muscarinic acetylcholine receptor Grant 11,339,156 - Acton, III , et al. May 24, 2	2022-05-24
Heteroaryl piperidine ether allosteric modulators of the M4 muscarinic acetylcholine receptor Grant 11,319,298 - Bao , et al. May 3, 2	2022-05-03
Preparation Of Benzimidazolone Derivatives As Novel Diacylglyceride O-acyltransferase 2 Inhibitors App 20220112182 - Lim; Yeon-Hee ; et al.	2022-04-14
Preparation Of Oxindole Derivatives As Novel Diacylglyceride O-acyltransferase 2 Inhibitors App 20220112181 - Lim; Yeon-Hee ; et al.	2022-04-14
3-(1h-pyrazol-4-yl)pyridine Allosteric Modulators Of The M4 Muscarinic Acetylcholine Receptor App 20210395224 - Acton, III; John J. ; et al.	2021-12-23
3-(1h-pyrazol-4-yl)pyridine Allosteric Modulators Of The M4 Muscarinic Acetylcholine Receptor App 20210380580 - ACTON, III; John J. ; et al.	2021-12-09
Novel Diacylglyceride O-acyltransferase 2 Inhibitors App 20210363147 - Lim; Yeon-Hee ; et al.	2021-11-25
3-(1H-pyrazol-4-yl)pyridine allosteric modulators of the M4 muscarinic acetylcholine receptor Grant 11,149,036 - Acton, III , et al. October 19, 2	2021-10-19
5-(pyridin-3-yl)oxazole allosteric modulators of the M4 muscarinic acetylcholine receptor Grant 10,981,902 - Bao , et al. April 20, 2	2021-04-20
3-(1H-pyrazol-4-yl)pyridine allosteric modulators of the M4 muscarinic acetylcholine receptor Grant 10,933,056 - Acton, III , et al. March 2, 2	2021-03-02
3-(1h-pyrazol-4-yl)pyridine Allosteric Modulators Of The M4 Muscarinic Acetylcholine Receptor App 20200207758 - ACTON, III; John J. ; et al.	2020-07-02
5-(pyridin-3-yl)oxazole Allosteric Modulators Of The M4 Muscarinic Acetylcholine Receptor App 20200109137 - BAO; Jianming ; et al.	2020-04-09
3-(1h-pyrazol-4-yl)pyridine Allosteric Modulators Of The M4 Muscarinic Acetylcholine Receptor App 20200069671 - Acton, III; John J. ; et al.	2020-03-05
Heteroaryl Piperidine Ether Allosteric Modulators Of The M4 Muscarinic Acetylcholine Receptor App 20190315708 - BAO; Jianming ; et al.	2019-10-17
6,7-dihydro-5H-pyrrolo[3,4-B]pyridin-5-one allosteric modulators of the M4 muscarinic acetylcholine receptor Grant 10,329,289 - Bao , et al.	2019-06-25
6,7-dihydro-5h-pyrrolo[3,4-b]pyridin-5-one Allosteric Modulators Of The M4 Muscarinic Acetylcholine Receptor App 20190062331 - BAO; JIANMING ; et al.	2019-02-28
3-(1h-pyrazol-4-yl)pyridine Allosteric Modulators Of The M4 Muscarinic Acetylcholine Receptor App 20190000824 - Acton, III; John J. ; et al.	2019-01-03
TrkA kinase inhibitors, compositions and methods thereof Grant 9,815,846 - Mitchell , et al. November 14, 2	2017-11-14
Spirocyclic CETP inhibitors Grant 9,717,714 - Ondeyka , et al. August 1, 2	2017-08-01
6,7-dihydro-5h-pyrrolo[3,4-b]pyridin-5-one Allosteric Modulators Of The M4 Muscarinic Acetylcholine Receptor App 20170183342 - BAO; JIANMING ; et al.	2017-06-29
Trka Kinase Inhibitors, Compositions And Methods Thereof App 20170114071 - Mitchell; Helen ; et al.	2017-04-27
Spirocyclic Cetp Inhibitors App 20150342931 - Ondeyka; Debra ; et al.	2015-12-03
Spiroxazolidinone compounds Grant 8,742,110 - Duffy , et al. June 3, 2	2014-06-03
Cyclic benzimidazole derivatives useful as anti-diabetic agents Grant 8,563,746 - Dang , et al. October 22, 2	2013-10-22
Spiroxazolidinone Compounds App 20130131042 - Duffy; Joseph L. ; et al.	2013-05-23
Cyclic benzimidazole derivatives useful as anti-diabetic agents Grant 8,410,284 - Dang , et al. April 2, 2	2013-04-02
Cyclic benzimidazole derivatives useful as anti-diabetic agents Grant 8,394,969 - Bookser , et al. March 12, 2	2013-03-12
Spiro Isoxazoline Compounds As Sstr5 Antagonists App 20130040978 - Duffy; Joseph L. ; et al.	2013-02-14
Cyclic benzimidazole derivatives useful as anti-diabetic agents Grant 8,329,914 - Bao , et al. December 11, 2	2012-12-11
Hydroxymethyl ether hydroisoindoline tachykinin receptor antagonists Grant 8,124,633 - DeVita , et al. February 28, 2	2012-02-28
Novel Cyclic Benzimidazole Derivatives Useful As Anti-diabetic Agents App 20110263533 - Dang; Qun ; et al.	2011-10-27
Novel Cyclic Benzimidazole Derivatives Useful As Anti-diabetic Agents App 20110218174 - Bao; Jianming ; et al.	2011-09-08
Novel Cyclic Benzimidazole Derivatives Useful As Anti-diabetic Agents App 20110195964 - Dang; Qun ; et al.	2011-08-11
Substituted 3-alkyl and 3-alkenyl azetidine derivatives Grant 7,906,503 - Baker , et al. March 15, 2	2011-03-15
6.5 -pyrrolopiperidine Tachykinin Receptor Antagonists App 20100197724 - Bao; Jianming ; et al.	2010-08-05
Hydroxymethyl Ether Hydroisoindoline Tachykinin Receptor Antagonists App 20100105747 - DeVita; Robert J. ; et al.	2010-04-29
Novel Cyclic Benzimidazole Derivatives Useful As Anti-diabetic Agents App 20100081643 - BOOKSER; BRETT C. ; et al.	2010-04-01
5,6,Fused Pyrrolidine Compounds Useful as Tachykinin Receptor Antagonists App 20090286777 - Bao; Jianming ; et al.	2009-11-19
Substituted 3-alkyl and 3-alkenyl azetidine derivatives App 20090069284 - Baker; Robert K. ; et al.	2009-03-12
Octahydropyrano[3,4-C]Pyrrole Tachykinin Receptor Antagonists App 20090048248 - DeVita; Robert J. ; et al.	2009-02-19
Hexahydro-3H-Pyrrolizin-3-Ones Useful as Tachykinin Receptor Antagonists App 20090042854 - Bao; Jianming ; et al.	2009-02-12
Substituted 3-alkyl and 3-alkenyl azetidine derivatives Grant 7,485,732 - Baker , et al. February 3, 2	2009-02-03
8-Phenyl-5,6,7,8-Hydroquinoline Tachykinin Receptor Antagonists App 20080039494 - Bao; Jianming ; et al.	2008-02-14
Substituted 3-alkyl and 3-alkenyl azetidine derivatives App 20060293299 - Baker; Robert K. ; et al.	2006-12-28
(Halo-benzo carbonyl)heterocyclo fused phenyl p38 kinase inhibiting agents Grant 6,809,199 - Doherty , et al. October 26, 2	2004-10-26
Carbocyclic potassium channel inhibitors Grant 6,632,836 - Baker , et al. October 14, 2	2003-10-14
(Halo-benzo carbonyl)heterocyclo fused phenyl p38 kinase inhibiting agents App 20030092712 - Doherty, James B. ; et al.	2003-05-15
3-alkyl substituted pyrrolidine modulators of chemokine receptor activity Grant 6,489,354 - Bao , et al. December 3, 2	2002-12-03
3-thienyl and 3-furanyl pyrrolidine modulators of chemokine receptor activity Grant 6,303,593 - Bao , et al. October 16, 2	2001-10-16
Triterpene derivatives with immunosuppressant activity Grant 5,952,371 - Baker , et al. September 14, 1	1999-09-14
Triterpene derivatives with immunosuppressant activity Grant 5,763,478 - Baker , et al. June 9, 1	1998-06-09
Triterpene derivatives with immunosuppressant activity Grant 5,696,156 - Baker , et al. December 9, 1	1997-12-09

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.